Advance Alzheimer’s biomarker detection with SPEAR UltraDetect pTau 217

13 Mar 2025

SPEAR UltraDetect pTau 217 is transforming Alzheimer’s disease research with its ultra-sensitive, blood-based assay. Using SPEAR Technology, this tool delivers high accuracy in distinguishing Alzheimer’s from other neurodegenerative diseases, enabling early detection, precise patient selection for clinical trials, and effective disease monitoring.

Links

Tags